Clinical Trial Update: Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial investigating SZC for effects on serum potassium and bicarbonate in patients with hyperkalemia and metabolic acidosis related to chronic kidney di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperkalemia
• Metabolic Acidosis

Drugs mentioned

• SZC (sodium zirconium cyclosilate)

Snippet

Sponsor: AstraZeneca | Conditions: Hyperkalaemia, Metabolic Acidosis | Phase 3 | Status: TERMINATED | Results posted: 2023-10-06